Nymox Pharmaceutical Corporation news

   Watch this stock
Showing stories 1 - 10 of about 10   

Articles published

NYMX 4.96 -0.19 (-3.69%)
price chart
NYMO: Critical Decision Point
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is at levels where you tend to see a bit of a bobble, followed by a continued strong move up.
Related articles »  
Top Wall Street Stories: Groupon (NASDAQ:GRPN), Halcon Resources (NYSE ...
Nymox Pharmaceutical Corporation on 10 September (NASDAQ:NYMX) announced new positive outcome results from the Company's ongoing prospective NX03-0040 trial of NX-1207 for the treatment of low grade localized prostate cancer.
Related articles »  
Hot Alert: Arena Pharmaceuticals (NASDAQ:ARNA), Stratasys (NASDAQ:SSYS ...
On 10 September Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced new positive outcome results from its ongoing prospective NX03-0040 trial of NX-1207 for the treatment of low grade localized prostate cancer.
Related articles »  
NASDAQ Top Losers After-Hours � ASNA, BCRX, MPET, EOPN, NYMX, PCRX ...
Nymox Pharmaceutical Corporation (NASDAQ: NYMX) traded at $4.1 down -3.3 percent during After Hours sessions on 8180 total share volume.
Related articles »